1. Home
  2. CALX vs VERA Comparison

CALX vs VERA Comparison

Compare CALX & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CALX
  • VERA
  • Stock Information
  • Founded
  • CALX 1999
  • VERA 2016
  • Country
  • CALX United States
  • VERA United States
  • Employees
  • CALX N/A
  • VERA N/A
  • Industry
  • CALX Telecommunications Equipment
  • VERA Biotechnology: Pharmaceutical Preparations
  • Sector
  • CALX Consumer Discretionary
  • VERA Health Care
  • Exchange
  • CALX Nasdaq
  • VERA Nasdaq
  • Market Cap
  • CALX 2.4B
  • VERA 2.5B
  • IPO Year
  • CALX 2010
  • VERA 2021
  • Fundamental
  • Price
  • CALX $37.11
  • VERA $42.01
  • Analyst Decision
  • CALX Strong Buy
  • VERA Strong Buy
  • Analyst Count
  • CALX 6
  • VERA 9
  • Target Price
  • CALX $42.50
  • VERA $53.56
  • AVG Volume (30 Days)
  • CALX 368.7K
  • VERA 683.6K
  • Earning Date
  • CALX 10-28-2024
  • VERA 11-07-2024
  • Dividend Yield
  • CALX N/A
  • VERA N/A
  • EPS Growth
  • CALX N/A
  • VERA N/A
  • EPS
  • CALX N/A
  • VERA N/A
  • Revenue
  • CALX $890,128,000.00
  • VERA N/A
  • Revenue This Year
  • CALX N/A
  • VERA N/A
  • Revenue Next Year
  • CALX $4.01
  • VERA N/A
  • P/E Ratio
  • CALX N/A
  • VERA N/A
  • Revenue Growth
  • CALX N/A
  • VERA N/A
  • 52 Week Low
  • CALX $26.76
  • VERA $9.68
  • 52 Week High
  • CALX $45.15
  • VERA $50.78
  • Technical
  • Relative Strength Index (RSI)
  • CALX 50.00
  • VERA 52.57
  • Support Level
  • CALX $36.89
  • VERA $39.22
  • Resistance Level
  • CALX $40.41
  • VERA $50.00
  • Average True Range (ATR)
  • CALX 1.16
  • VERA 2.41
  • MACD
  • CALX -0.08
  • VERA 0.24
  • Stochastic Oscillator
  • CALX 34.89
  • VERA 28.53

About CALX Calix Inc

Calix Inc develops, market and sell Calix cloud, systems and software platforms to enable service providers of all types and sizes to innovate and transform. The company's customers utilize the real-time data and insights from Calix platforms to simplify their business and deliver experiences that excite their subscribers. The resulting growth in subscriber acquisition, loyalty and revenue creates more value for their businesses and communities. The Company's revenue is principally derived in the United States and it also has its presence in Middle East & Africa, Europe, Asia Pacific and other markets.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: